Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Vaalco Energy
EGY
$619M
| $3.42M | ﹤0.01% |
3,795,642
+48,452
| +1% | +$91.7K |
|
|
MTLS
1777
Materialise
MTLS
$395M
| $3.42M | ﹤0.01% |
184,300
-16,500
| -8% | -$285K |
|
|
BVH
1778
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $3.42M | ﹤0.01% |
295,755
+7,387
| +3% | +$126K |
|
|
ORBC
1779
DELISTED
ORBCOMM, Inc.
ORBC
| $3.41M | ﹤0.01% |
1,398,138
+1,150,018
| +463% | +$3.75M |
|
|
CAMP
1780
DELISTED
CalAmp Corp.
CAMP
| $3.4M | ﹤0.01% |
32,848
-12,426
| -27% | -$2.43M |
|
1781
iShares Silver Trust
SLV
$30.7B
| $3.38M | ﹤0.01% |
259,306
+46,506
| +22% | +$731K |
|
|
EIDX
1782
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $3.38M | ﹤0.01% |
69,001
+62,918
| +1,034% | +$3.21M |
|
1783
Compugen
CGEN
$222M
| $3.38M | ﹤0.01% |
464,900
-262,100
| -36% | -$2.06M |
|
1784
Northeast Bank
NBN
$1.12B
| $3.37M | ﹤0.01% |
289,345
-24,400
| -8% | -$442K |
|
|
MASI
1785
DELISTED
Masimo
MASI
| $3.37M | ﹤0.01% |
19,000
-7,021
| -27% | -$1.2M |
|
|
VSA
1786
VisionSys AI
VSA
$8.77M
| $3.35M | ﹤0.01% |
350
-70
| -17% | -$520K |
|
1787
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $3.35M | ﹤0.01% |
+47,500
| New | +$3.22M |
|
1788
Monarch Casino & Resort
MCRI
$2.21B
| $3.34M | ﹤0.01% |
119,103
-86,500
| -42% | -$3.79M |
|
|
EXTN
1789
DELISTED
Exterran Corporation
EXTN
| $3.34M | ﹤0.01% |
696,300
-44,800
| -6% | -$269K |
|
|
SAFE
1790
DELISTED
Safehold Inc.
SAFE
| $3.34M | ﹤0.01% |
+52,800
| New | +$2.67M |
|
1791
Edgewell Personal Care
EPC
$1.3B
| $3.33M | ﹤0.01% |
138,500
-134,300
| -49% | -$4.01M |
|
|
JNCE
1792
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.33M | ﹤0.01% |
700,114
+290,200
| +71% | +$1.67M |
|
|
CFMS
1793
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.32M | ﹤0.01% |
210,610
+12,235
| +6% | +$299K |
|
|
KNL
1794
DELISTED
Knoll, Inc.
KNL
| $3.32M | ﹤0.01% |
321,441
-32,959
| -9% | -$656K |
|
1795
Schneider National
SNDR
$6.25B
| $3.31M | ﹤0.01% |
171,200
-245,500
| -59% | -$5.09M |
|
1796
Liberty Latin America Class A
LILA
$1.67B
| $3.31M | ﹤0.01% |
491,451
-29,094
| -6% | -$293K |
|
1797
Aclaris Therapeutics
ACRS
$832M
| $3.3M | ﹤0.01% |
3,175,636
+393,339
| +14% | +$535K |
|
|
TSC
1798
DELISTED
TriState Capital Holdings, Inc.
TSC
| $3.3M | ﹤0.01% |
341,623
+110,923
| +48% | +$2.22M |
|
1799
Natural Alternatives International
NAII
$15M
| $3.3M | ﹤0.01% |
524,121
-25,477
| -5% | -$191K |
|
|
ARCE
1800
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $3.3M | ﹤0.01% |
78,000
-80,500
| -51% | -$3.99M |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.